Financial Year |
March 31 2023 |
Monetary Funds |
771,284,512.52 |
Held-for-trading Financial Assets |
40,097,315.07 |
Notes Receivable |
-- |
Accounts Receivable |
141,546,450.62 |
Advances to Suppliers |
374,883.65 |
Other Receivables |
1,432,011.09 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
128,662,454.72 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
9,565,203.61 |
Total Current Assets |
1,092,962,831.28 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
1,366,669.25 |
Fixed Assetes |
165,335,430.05 |
Under-construction Projects |
1,852,908.52 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
14,260,284.18 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
505,078.43 |
Deferred Income Tax Assets |
8,204,115.21 |
Other Non-Current Assets |
213,816.38 |
Sub-Total of Non-Current Assets |
192,272,685.46 |
Total Assets |
1,285,235,516.74 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
50,336,922.68 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
31,684,315.31 |
Taxes Payable |
2,378,470.79 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,613,440.01 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
379,324.07 |
Other Current Liabilities |
50,116.24 |
Sub-Total of Current Liabilities |
98,848,256.01 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
1,386,333.50 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
115,678.40 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
6,167,283.87 |
Total Liabilities |
105,015,539.88 |
Paid-In Capital(Or Share Stock) |
69,359,759.00 |
Capital Surplus |
724,769,644.37 |
Surplus Reserve |
54,227,741.44 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
331,527,912.34 |
Minority Stockholder's Interest |
334,919.71 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,179,885,057.15 |
Owner's Equity(Stockholder's Equity) |
1,180,219,976.86 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,285,235,516.74 |